Top Markets
Coin of the day
BCAL Diagnostics Limited BCAL Diagnostics Limited

BCAL Diagnostics Limited

BDX
Classement en actions #31190
BCAL Diagnostics Limited is a biotechnology firm focused on creating an... BCAL Diagnostics Limited is a biotechnology firm focused on creating an advanced, non-surgical laboratory blood test for the identification of breast cancer. Its flagship product, the BCAL test, is a lipid biomarker-based blood assay designed for potential use in breast cancer prevention strategies, early screening, and ongoing patient monitoring. This in vitro diagnostic (IVD) technology functions by detecting a unique pattern of lipid biomarkers, which are isolated from extracellular vesicles present in a patient's plasma or blood, thereby enabling the diagnosis of breast cancer cells. Established in 2010, the company's main operations are based in Sydney, Australia.
Prix de l'action
$0.03808538
Capitalisation boursière
$14.04M
Changement (1 jour)
-3.57%
Changement (1 an)
6.63%
Pays
AU
Échange BCAL Diagnostics Limited (BDX)

Catégorie

Ratio P/S pour BCAL Diagnostics Limited (BDX)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de BCAL Diagnostics Limited, le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour BCAL Diagnostics Limited de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
4.72 -
US
5.67 -
US
- -
CN
16.40 -
US
9.55 -
US